New cell and gene therapies currently face many regulatory hurdles on the way to getting to market. This article published by the Innovative Health Initiative (IHI) outlines T2EVOLVE’s recommendations to adjust regulatory processes and enable more developments of new treatments.

You can find both the news article and published paper below.

Share This